Analysed ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) News Sources
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
23-03-2026
yahoo.com
ESLA: Initiating Coverage of Estrella Immunopharma: A Potential Successor to Arcellx in Next-Generation CAR-T
18-03-2026
yahoo.com
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
09-02-2026
yahoo.com
Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
03-02-2026
yahoo.com
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
06-01-2026
yahoo.com
Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
05-01-2026
yahoo.com
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
04-12-2025
yahoo.com
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either?
04-11-2025
barchart.com
What is the current price of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The current price of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is $1.88.
ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) since the previous trading day is $0.22.
ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) since the previous trading day is 13.253%.
What is the most recent average sentiment score for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The most recent average sentiment score for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The most recent sentiment for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is .
SEC-8K** Filing Available For ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.